Market Analysis and Price Projections for NDC 51862-0896: Tilia Fe
Introduction to Tilia Fe
Tilia Fe, with the National Drug Code (NDC) 51862-0896, is a prescription medication manufactured by Mayne Pharma Inc. It is a combination of norethindrone and ethinyl estradiol, and it also contains ferrous fumarate, making it a contraceptive and iron supplement[1].
Market Context
The pharmaceutical market is dynamic and influenced by various factors, including regulatory changes, new drug approvals, and economic trends.
Drug Price Inflation
According to Vizient's summer 2024 Pharmacy Market Outlook, the overall drug price inflation rate for pharmaceuticals in 2025 is projected to be 3.81%. This inflation is partly driven by the expanding indications of previously approved medications and the introduction of high-cost cell and gene therapies[2].
Impact of New Indications
The trend of expanding indications for existing medications, such as GLP-1 agents like semaglutide, can significantly impact pharmacy spend. While Tilia Fe is not directly affected by these specific trends, the overall increase in drug prices can influence the pricing strategy for all pharmaceuticals[2].
Manufacturer Overview
Mayne Pharma Inc., the manufacturer of Tilia Fe, has a diverse portfolio of drugs. The company's pricing strategies are likely influenced by market conditions, competition, and regulatory requirements.
Product Portfolio
Mayne Pharma's product list includes a range of medications, from cardiovascular drugs like amiodarone to dermatological treatments like flurandrenolide. The company's ability to manage a broad portfolio can impact its pricing decisions for individual products like Tilia Fe[1].
Pricing Trends
Pricing trends for pharmaceuticals are complex and can be influenced by several factors, including production costs, market demand, and regulatory approvals.
Historical Pricing Data
While specific historical pricing data for NDC 51862-0896 is not readily available, the general trend in pharmaceutical pricing suggests that prices can fluctuate based on market conditions. For example, other medications have seen price changes due to various market and regulatory factors[4].
Regulatory Influence
The FDA's National Drug Code Directory and other regulatory frameworks can influence pricing by affecting the cost of production and distribution. Outsourcing facilities, for instance, may have different pricing strategies due to exemptions from certain drug registration and listing requirements[5].
Future Price Projections
Given the projected 3.81% drug price inflation rate for 2025, it is reasonable to anticipate that the price of Tilia Fe could increase accordingly.
Economic Factors
Economic factors such as inflation, production costs, and market demand will play a significant role in determining the future price of Tilia Fe. As the pharmaceutical market continues to evolve, manufacturers may adjust prices to maintain profitability.
Technological and Regulatory Changes
The adoption of artificial intelligence (AI) and other health technologies in the pharmaceutical industry could also impact pricing. For instance, AI can help in optimizing production processes and reducing costs, which might stabilize or reduce prices in the long term[3].
Competitive Landscape
The contraceptive market is competitive, with several brands and generic options available. The pricing of Tilia Fe must be competitive to maintain market share.
Market Share and Competition
Tilia Fe competes with other combination oral contraceptives. The pricing strategy will need to balance competitiveness with the need to maintain profitability, especially in a market where generic alternatives are available.
Conclusion
The price of Tilia Fe, like other pharmaceuticals, is subject to various market and regulatory influences. Here are some key points to consider:
- Projected Inflation: A 3.81% drug price inflation rate for 2025 suggests that Tilia Fe's price could increase.
- Market Trends: Expanding indications for other medications and the introduction of high-cost therapies can impact overall market dynamics.
- Regulatory Influence: FDA regulations and outsourcing facility exemptions can affect production and distribution costs.
- Technological Advances: The adoption of AI and other health technologies may optimize production and reduce costs.
Key Takeaways
- Price Inflation: Anticipate a potential increase in the price of Tilia Fe due to overall drug price inflation.
- Market Dynamics: The competitive landscape and expanding indications for other medications can influence pricing strategies.
- Regulatory Impact: FDA regulations and outsourcing facility rules can affect production costs and pricing.
- Technological Impact: AI and health technologies may help in cost optimization and price stabilization.
FAQs
Q: What is the current price trend for pharmaceuticals in 2025?
A: The overall drug price inflation rate for pharmaceuticals in 2025 is projected to be 3.81% according to Vizient's summer 2024 Pharmacy Market Outlook[2].
Q: How does the adoption of AI impact pharmaceutical pricing?
A: The adoption of AI can help in optimizing production processes and reducing costs, which might stabilize or reduce prices in the long term[3].
Q: What factors influence the pricing of Tilia Fe?
A: Factors include market demand, production costs, regulatory approvals, and the competitive landscape within the contraceptive market.
Q: How does the FDA's National Drug Code Directory affect pricing?
A: The FDA's National Drug Code Directory influences pricing by affecting the cost of production and distribution, especially for outsourcing facilities[5].
Q: What is the impact of expanding indications for other medications on Tilia Fe's price?
A: While Tilia Fe is not directly affected, the overall increase in drug prices due to expanding indications for other medications can influence the pricing strategy for all pharmaceuticals[2].
Sources
- FindACode: Mayne Pharma - List of Drugs - NDC Labeler/Manufacturer
- Vizient: Vizient projects drug price inflation at 3.81%
- Intelligencia.ai: 2025 Pharma Predictions: AI, Health Tech, and Data Trends to Watch
- DrugPatentWatch: Latest pharmaceutical drug prices and trends for NDC 00904-5448
- FDA: National Drug Code Directory - FDA
